# Neuphoria Therapeutics Inc.: filings

NEUP · Nasdaq · CIK 1191070 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/neup.md) · [Financials](/companies/neup/financials.md) · [Filings](/companies/neup/filings.md) · [Insiders](/companies/neup/insiders.md)

## Reports and events: 91 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (6-K 48, 8-K 20, CORRESP 13, 4 11, DEFA14A 11, UPLOAD 10, EFFECT 9, 3 8, 424B5 7, 10-Q 6, SCHEDULE 13D/A 6, DFAN14A 5, SC 13G 5, SC 13G/A 5, SCHEDULE 13G 4, 10-K 3, DEF 14A 3, F-1 3, F-1/A 3, SCHEDULE 13G/A 3, 20-F 2, 424B4 2, DEFC14A 2, DRS 2, POS AM 2, PREC14A 2, S-3 2, S-3/A 2, S-8 2, 15-12G 1, 20-F/A 1, 424B3 1, 4/A 1, 8-A12B 1, CERT 1, D 1, DFRN14A 1, DRS/A 1, DRSLTR 1, F-1MEF 1, F-3 1, NT 10-Q 1, PRE 14A 1, SC 13D 1, SC 13D/A 1, SCHEDULE 13D 1, SUPPL 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 08:00 ET | [8-K](/filings/0001213900-26-111863.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001213900-26-111863 |
| 2026-09-18 | 20:33 ET | [DEF 14A](/filings/0001140361-26-037139.md) | Proxy statement, period 2026-11-02 | 0001140361-26-037139 |
| 2026-09-18 | 20:10 ET | [10-K](/filings/0001193125-26-395536.md) | Annual report, period 2026-06-30 | 0001193125-26-395536 |
| 2026-07-24 | 22:37 ET | [8-K](/filings/0001213900-26-081052.md) | 1.01 Entry into a material agreement; 5.01 Change in control; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-081052 |
| 2026-05-26 | 20:15 ET | [8-K](/filings/0001213900-26-061028.md) | 8.01 Other events | 0001213900-26-061028 |
| 2026-05-15 | 12:33 ET | [10-Q](/filings/0001193125-26-225442.md) | Quarterly report, period 2026-03-31 | 0001193125-26-225442 |
| 2026-02-17 | 20:57 ET | [10-Q](/filings/0001193125-26-054509.md) | Quarterly report, period 2025-12-31 | 0001193125-26-054509 |
| 2026-01-08 | 22:48 ET | [8-K](/filings/0001213900-26-002245.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-002245 |
| 2025-12-29 | 21:33 ET | [SCHEDULE 13D/A](/filings/0000905148-25-004490.md) | Ownership report, active investor, amended | 0000905148-25-004490 |
| 2025-12-18 | 21:15 ET | [8-K](/filings/0001213900-25-123289.md) | 3.01 Delisting notice | 0001213900-25-123289 |
| 2025-12-17 | 21:01 ET | [8-K](/filings/0001213900-25-122777.md) | 5.07 Shareholder vote results | 0001213900-25-122777 |
| 2025-12-02 | 13:20 ET | [SCHEDULE 13D/A](/filings/0000905148-25-004208.md) | Ownership report, active investor, amended | 0000905148-25-004208 |
| 2025-11-28 | 14:09 ET | [SCHEDULE 13D/A](/filings/0000905148-25-004191.md) | Ownership report, active investor, amended | 0000905148-25-004191 |
| 2025-11-18 | 13:25 ET | [SCHEDULE 13D/A](/filings/0000905148-25-004110.md) | Ownership report, active investor, amended | 0000905148-25-004110 |
| 2025-11-14 | 12:34 ET | [10-Q](/filings/0001193125-25-281579.md) | Quarterly report, period 2025-09-30 | 0001193125-25-281579 |
| 2025-11-10 | 19:33 ET | [SCHEDULE 13D/A](/filings/0000905148-25-003859.md) | Ownership report, active investor, amended | 0000905148-25-003859 |
| 2025-10-30 | 00:04 ET | [DEF 14A](/filings/0001140361-25-039748.md) | Proxy statement, period 2025-12-09 | 0001140361-25-039748 |
| 2025-10-27 | 20:19 ET | [8-K](/filings/0001213900-25-102607.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-102607 |
| 2025-10-23 | 23:52 ET | [SCHEDULE 13D](/filings/0000902664-25-004537.md) | Ownership report, active investor | 0000902664-25-004537 |
| 2025-10-20 | 20:15 ET | [8-K](/filings/0001213900-25-100371.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-100371 |
| 2025-09-29 | 20:46 ET | [10-K](/filings/0001193125-25-223338.md) | Annual report, period 2025-06-30 | 0001193125-25-223338 |
| 2025-09-16 | 13:03 ET | [8-K](/filings/0001213900-25-087950.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-25-087950 |
| 2025-07-18 | 21:00 ET | [8-K](/filings/0001213900-25-065723.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-25-065723 |
| 2025-05-20 | 20:15 ET | [8-K](/filings/0001213900-25-045970.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-045970 |
| 2025-05-20 | 20:06 ET | [10-Q](/filings/0000950170-25-075175.md) | Quarterly report, period 2025-03-31 | 0000950170-25-075175 |
| 2025-02-14 | 13:58 ET | [10-Q](/filings/0000950170-25-020473.md) | Quarterly report, period 2024-12-31 | 0000950170-25-020473 |
| 2025-01-28 | 21:30 ET | [SCHEDULE 13D/A](/filings/0000950170-25-009848.md) | Ownership report, active investor, amended | 0000950170-25-009848 |
| 2025-01-14 | 22:28 ET | [8-K](/filings/0001213900-25-003492.md) | 8.01 Other events | 0001213900-25-003492 |
| 2024-12-23 | 22:14 ET | [8-K](/filings/0001213900-24-112016.md) | 1.01 Entry into a material agreement; 3.01 Delisting notice; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-112016 |
| 2024-12-16 | 21:46 ET | [8-K](/filings/0001213900-24-109347.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-109347 |
| 2024-12-12 | 22:02 ET | [8-K](/filings/0001213900-24-108436.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-24-108436 |
| 2024-11-21 | 21:01 ET | [8-K](/filings/0001213900-24-100971.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-100971 |
| 2024-11-14 | 21:05 ET | [10-Q](/filings/0000950170-24-127032.md) | Quarterly report, period 2024-09-30 | 0000950170-24-127032 |
| 2024-11-12 | 21:06 ET | [DEF 14A](/filings/0001213900-24-096782.md) | Proxy statement, period 2024-12-11 | 0001213900-24-096782 |
| 2024-11-08 | 21:30 ET | [8-K](/filings/0001213900-24-095926.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-095926 |
| 2024-10-10 | 21:00 ET | [8-K](/filings/0001213900-24-086918.md) | 5.02 Departure or appointment of officers or directors | 0001213900-24-086918 |
| 2024-10-07 | 22:10 ET | [SC 13D/A](/filings/0001193125-24-233941.md) | Ownership report, active investor, amended | 0001193125-24-233941 |
| 2024-10-02 | 22:01 ET | [8-K](/filings/0001213900-24-084175.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-084175 |
| 2024-09-30 | 10:38 ET | [10-K](/filings/0001213900-24-082909.md) | Annual report, period 2024-06-30 | 0001213900-24-082909 |
| 2024-07-16 | 10:30 ET | [8-K](/filings/0001213900-24-061529.md) | 3.01 Delisting notice | 0001213900-24-061529 |
| 2024-06-03 | 21:18 ET | [6-K](/filings/0000950170-24-068125.md) | Report of a foreign private issuer, period 2024-06-03 | 0000950170-24-068125 |
| 2024-03-15 | 10:06 ET | [6-K](/filings/0000950170-24-031859.md) | Report of a foreign private issuer, period 2024-03-15 | 0000950170-24-031859 |
| 2024-01-04 | 11:04 ET | [6-K](/filings/0000950170-24-001476.md) | Report of a foreign private issuer, period 2024-01-04 | 0000950170-24-001476 |
| 2023-11-30 | 11:02 ET | [6-K](/filings/0000950170-23-066890.md) | Report of a foreign private issuer, period 2023-11-30 | 0000950170-23-066890 |
| 2023-11-28 | 11:03 ET | [6-K](/filings/0000950170-23-066236.md) | Report of a foreign private issuer, period 2023-11-28 | 0000950170-23-066236 |
| 2023-11-03 | 10:03 ET | [6-K](/filings/0000950170-23-058491.md) | Report of a foreign private issuer, period 2023-11-03 | 0000950170-23-058491 |
| 2023-10-18 | 10:42 ET | [20-F](/filings/0000950170-23-053873.md) | Annual report of a foreign private issuer, period 2023-06-30 | 0000950170-23-053873 |
| 2023-10-16 | 10:03 ET | [6-K](/filings/0000950170-23-053390.md) | Report of a foreign private issuer, period 2023-10-16 | 0000950170-23-053390 |
| 2023-09-29 | 10:04 ET | [6-K](/filings/0000950170-23-050573.md) | Report of a foreign private issuer, period 2023-09-29 | 0000950170-23-050573 |
| 2023-09-28 | 11:00 ET | [6-K](/filings/0000950170-23-050234.md) | Report of a foreign private issuer, period 2023-09-28 | 0000950170-23-050234 |

Page 1 of 2. [Older](/companies/neup/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.